p-Coumaric acid modulates cholesterol efflux and lipid accumulation and inflammation in foam cells

키워드

참고문헌 (114)

1. Levenson JW, "Reducing the global burden of cardiovascular disease : the role of risk factors", Prev Cardiol, 5, pp.188~199 (2002)
2. Joshi R, "Global inequalities in access to cardiovascular health care : our greatest challenge", J Am Coll Cardiol, 52, pp.1817~1825 (2008)
3. Björkegren JLM, "Atherosclerosis : recent developments", Cell, 185, pp.1630~1645 (2022)
4. Paulson KE, "Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis", Circ Res, 106, pp.383~390 (2010)
5. Ley K, "Monocyte and macrophage dynamics during atherogenesis", Arterioscler Thromb Vasc Biol, 31, pp.1506~1516 (2011)
6. Rafieian-Kopaei M, "Atherosclerosis : process, indicators, risk factors and new hopes", Int J Prev Med, 5, pp.927~946 (2014)
7. Su Y, "Neutrophils and macrophages as targets for development of nanotherapeutics in inflammatory diseases", Pharmaceutics, 12, pp.1222~ (2020)
8. -humanin inhibits ox-LDL uptake and stimulates cholesterol efflux in macrophage-derived foam cells, "Biochem Biophys Res Commun", 2017, 93~99
9. Guo C, "Silica nanoparticles promote oxLDL-induced macrophage lipid accumulation and apoptosis via endoplasmic reticulum stress signaling", Sci Total Environ (2018)
10. Ait-Oufella H, "Recent advances on the role of cytokines in atherosclerosis", Arterioscler Thromb Vasc Biol, 31, pp.969~979 (2011)
11. Yi BG, "In vitro photodynamic effects of scavenger receptor targeted-photoactivatable nanoagents on activated macrophages", Int J Biol Macromol, 97, pp.181~189 (2017)
12. Wang G, "Discrepancies in the in vitro and in vivo role of scavenger receptors in clearance of nanoparticles by Kupffer cells", Precis Nanomed, 1, pp.76~84 (2018)
13. Moore KJ, "Scavenger receptors in atherosclerosis : beyond lipid uptake", Arterioscler Thromb Vasc Biol, 26, pp.1702~1711 (2006)
14. Ghosh S, "Macrophage cholesteryl ester mobilization and atherosclerosis", Vascul Pharmacol, 52, pp.1~10 (2010)
15. Wang M, "Qihuang zhuyu formula attenuates atherosclerosis via targeting PPARγ to regulate cholesterol efflux and endothelial cell inflammation", Oxid Med Cell Longev, 2022, pp.2226168~ (2022)
16. Wu C, "Chlorogenic acid protects against atherosclerosis in ApoE-", -mice and promotes cholesterol efflux from RAW264. 7 macrophages, 2014, pp.9, e95452~
17. Badimón JJ, "Increasing high-density lipoprotein as a therapeutic target in atherothrombotic disease", Rev Esp Cardiol, 63, pp.323~333 (2010)
18. Chen W, "A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes", J Biol Chem, 280, pp.29277~29281 (2005)
19. Wang J, "Role of ABCA1 in cardiovascular disease", J Pers Med, 12, pp.1010~ (2022)
20. Costet P, "Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor", retinoid X receptor, 2000, pp.275, 28240~28245
21. Repa JJ, "Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers", Science, 289, pp.1524~1529 (2000)
22. Chinetti G, "PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway", Nat Med, 7, pp.53~58 (2001)
23. Spagnoli LG, "Role of inflammation in atherosclerosis", J Nucl Med, 48, pp.1800~1815 (2007)
24. Tipping PG, "Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques", Am J Pathol, 142, pp.1721~1728 (1993)
25. Barath P, "Detection and localization of tumor necrosis factor in human atheroma", Am J Cardiol, 65, pp.297~302 (1990)
26. Yurdagul A Jr, "Oxidized LDL induces FAK-dependent RSK signaling to drive NF-κB activation and VCAM-1 expression", J Cell Sci, 129, pp.1580~1591 (2016)
27. de Winther MP, "Nuclear factor κB signaling in atherogenesis", Arterioscler Thromb Vasc Biol, 25, pp.904~914 (2005)
28. Cheng ZJ, "Angiotensin II and vascular inflammation", Med Sci Monit (2005)
29. Benigni A, "Angiotensin II revisited : new roles in inflammation, immunology and aging", EMBO Mol Med, 2, pp.247~257 (2010)
30. Salazar G, "NADPH oxidases and mitochondria in vascular senescence", Int J Mol Sci, 19, pp.1327~ (2018)
31. Zeng HT, "SIRT1 prevents atherosclerosis via liver-X-receptor and NF-κB signaling in a U937 cell model", Mol Med Rep, 8, pp.23~28 (2013)
32. Li Y, "SIRT1 inhibits inflammatory response partly through regulation of NLRP3 inflammasome in vascular endothelial cells", Mol Immunol, 77, pp.148~156 (2016)
33. Yoshizaki T, "SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity", Am J Physiol Endocrinol Metab, 298, pp.E419~28 (2010)
34. Pfluger PT, "Sirt1 protects against high-fat diet-induced metabolic damage", Proc Natl Acad Sci U S A, 105, pp.9793~9798 (2008)
35. Tabansi D, "Anti-atherosclerosis and anti-hyperlipidemia functions of Terminalia catappa fruit", ACS Omega, 8, pp.35571~35579 (2023)
36. Hu R, "Dietary ferulic acid and vanillic acid on inflammation, gut barrier function and growth performance in lipopolysaccharide-challenged piglets", Anim Nutr, 8, pp.144~152 (2022)
37. Joo HK, "Anthocyanin-rich extract from red chinese cabbage alleviates vascular inflammation in endothelial cells and Apo E-", -mice, 2018, pp.19, 816~
38. Wang P, "Protective effects of dietary resveratrol against chronic low-grade inflammation mediated through the gut microbiota in high-fat diet mice", Nutrients, 14, pp.1994~ (2022)
39. Jiang T, "Laquinimod protects against TNF-α-induced attachment of monocytes to human aortic endothelial cells(HAECs)by increasing the expression of KLF2", Drug Des Devel Ther, 14, pp.1683~1691 (2020)
40. Li J, "The effective constituent puerarin, from Pueraria lobata, inhibits the proliferation and inflammation of vascular smooth muscle in atherosclerosis through the miR-29b-3p", IGF1 pathway, 2023, pp.61, 1~11
41. Socha R, "Phenolic composition and antioxidant activity of propolis from various regions of Poland", Nat Prod Res, 29, pp.416~422 (2015)
42. Li H, "Antioxidant and anti-inflammatory activities of methanol extracts of Tremella fuciformis and its major phenolic acids", J Food Sci, 79, pp.460~468 (2014)
43. Kong CS, "Antiangiogenic effects of p-coumaric acid in human endothelial cells", Phytother Res, 27, pp.317~323 (2013)
44. Yoon JH, "p-Coumaric acid and ursolic acid from Corni fructus attenuated β-amyloid25-35-induced toxicity through regulation of the NF-κB signaling pathway in PC12 cells", J Agric Food Chem, 62, pp.4911~4916 (2014)
45. Luceri C, "p-Coumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo", Br J Nutr, 97, pp.458~463 (2007)
46. Morgan MJ, "Crosstalk of reactive oxygen species and NF-κB signaling", Cell Res, 21, pp.103~115 (2011)
47. Ha KH, "Epidemiologic characteristics of dyslipidemia in Korea", J Lipid Atheroscler, 4, pp.93~99 (2015)
48. WHO CVD Risk Chart Working Group, "World Health Organization cardiovascular disease risk charts : revised models to estimate risk in 21 global regions", Lancet Glob Health, 7, pp.1332~1345 (2019)
49. Oh K, "Korea National Health and Nutrition Examination Survey, 20th anniversary : accomplishments and future directions", Epidemiol Health, 43, pp.e2021025~ (2021)
50. Shin HY, "Cause-of-death statistics in 2018 in the Republic of Korea", J Korean Med Assoc, 63, pp.286~297 (2020)
51. Yuan Y, "Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis", Protein Cell, 3, pp.173~181 (2012)
52. Volobueva A, "Foam cell formation and cholesterol trafficking and metabolism disturbances in atherosclerosis", Cor Vasa, 61, pp.48~54 (2019)
53. Pennings M, "Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development", FEBS Lett, 580, pp.5588~5596 (2006)
54. Wang H, "DPP-4 inhibitor linagliptin ameliorates oxidized LDL-induced THP-1 macrophage foam cell formation and inflammation", Drug Des Devel Ther, 14, pp.3929~3940 (2020)
55. Yu XH, "Foam cells in atherosclerosis", Clin Chim Acta, 424, pp.245~252 (2013)
56. Wu X, "Ferulic acid alleviates atherosclerotic plaques by inhibiting VSMC proliferation through the NO", p21 signaling pathway, 2022, pp.15, 865~875
57. Ji W, "Resveratrol protects against atherosclerosis by downregulating the PI3K", AKT, Exp Ther Med, pp.2022, 23[DOI]
58. Singh L, "Curcumin as a natural remedy for atherosclerosis : a pharmacological review", Molecules, 26, pp.4036~ (2021)
59. Stojković D, "In situ antioxidant and antimicrobial activities of naturally occurring caffeic acid, p-coumaric acid and rutin, using food systems", J Sci Food Agric, 93, pp.3205~3208 (2013)
60. Pragasam SJ, "Immunomodulatory and anti-inflammatory effect of p-coumaric acid, a common dietary polyphenol on experimental inflammation in rats", Inflammation, 36, pp.169~176 (2013)
61. Stanciulescu LA, "Exploring the association between low-density lipoprotein subfractions and major adverse cardiovascular outcomes-a comprehensive review", Int J Mol Sci, 24, pp.6669~ (2023)
62. Kannel WB, "A general cardiovascular risk profile : the Framingham Study", Am J Cardiol, 38, pp.46~51 (1976)
63. Kannel WB, "Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study", Ann Intern Med, 90, pp.85~91 (1979)
64. Khatana C, "Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis", Oxid Med Cell Longev, 2020, pp.5245308~ (2020)
65. Detmers PA, "Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice", J Immunol, 165, pp.3430~3435 (2000)
66. Glass CK, "Atherosclerosis : the road ahead", Cell, 104, pp.503~516 (2001)
67. Farahi L, "Roles of macrophages in atherogenesis", Front Pharmacol, 12, pp.785220~ (2021)
68. Meng Z, "Oxidized low-density lipoprotein induces inflammatory responses in cultured human mast cells via Toll-like receptor 4", Cell Physiol Biochem, 31, pp.842~853 (2013)
69. Plotkin JD, "NF-κB inhibitors that prevent foam cell formation and atherosclerotic plaque accumulation", Nanomedicine, 13, pp.2037~2048 (2017)
70. Kim AT, "Anti-inflammatory effects of vanadium-binding protein from Halocynthia roretzi in LPS-stimulated RAW264. 7 macrophages through NF-κB and MAPK pathways", Int J Biol Macromol, 133, pp.732~738 (2019)
71. Adam GO, "Red ginseng reduces inflammatory response via suppression MAPK", P38 signaling and p65 nuclear proteins translocation in rats and raw 264. 7 macrophage, 2019, pp.47, 1589~1609
72. Zhang Y, "Natural products in atherosclerosis therapy by targeting PPARs : a review focusing on lipid metabolism and inflammation", Front Cardiovasc Med, 11, pp.1372055~ (2024)
73. Im YS, "Protective effects of phenethyl isothiocyanate on foam cell formation by combined treatment of oxidized low-density lipoprotein and lipopolysaccharide in THP-1 macrophage", Food Sci Nutr, 9, pp.3269~3279 (2021)
74. Wang D, "Sweroside alleviates pressure overload-induced heart failure through targeting CaMKIIδ to inhibit ROS-mediated NF-κB", NLRP3 in cardiomyocytes, 2024, pp.74, 103223~
75. He JH, "Eugenol inhibits ox-LDL-induced proliferation and migration of human vascular smooth muscle cells by inhibiting the Ang II", MFG-E8, J Inflamm Res, pp.2024, 17[DOI]
76. Xue F, "Quercetin inhibits LPS-induced inflammation and ox-LDL-induced lipid deposition", Front Pharmacol, 8, pp.40~ (2017)
77. Liu Y, "Mulberry extract upregulates cholesterol efflux and inhibits p38 MAPK-NLRP3-mediated inflammation in foam cells", Food Sci Nutr, 11, pp.3141~3153 (2023)
78. Levi M, "Infection and inflammation as risk factors for thrombosis and atherosclerosis", Semin Thromb Hemost, 38, pp.506~514 (2012)
79. Nelken NA, "Monocyte chemoattractant protein-1 in human atheromatous plaques", J Clin Invest, 88, pp.1121~1127 (1991)
80. Boyle JJ, "Tumor necrosis factor-α promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms", Arterioscler Thromb Vasc Biol, 23, pp.1553~1558 (2003)
81. Mussbacher M, "NF-κB in monocytes and macrophages-an inflammatory master regulator in multitalented immune cells", Front Immunol, 14, pp.1134661~ (2023)
82. Hashizume M, "Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors", Cytokine, 58, pp.424~430 (2012)
83. Shen W, "Atheroprotective mechanisms of tilianin by inhibiting inflammation through down-regulating NF-κB pathway and foam cells formation", Front Physiol, 10, pp.825~ (2019)
84. Lin CC, "Baicalein attenuates oxLDL-induced oxidative functional damages in endothelial cells", FASEB J, 24, pp.1038~ (2010)
85. Kuo MY, "Ellagic acid inhibits oxidized low-density lipoprotein(OxLDL)-induced metalloproteinase(MMP)expression by modulating the protein kinase C-α", extracellular signal-regulated kinase, nuclear factor-κB(PKC-α, pp.ERK, PPAR-γ[DOI]
86. Chistiakov DA, "Mechanisms of foam cell formation in atherosclerosis", J Mol Med(Berl), 95, pp.1153~1165 (2017)
87. Moore KJ, "Macrophages in the pathogenesis of atherosclerosis", Cell, 145, pp.341~355 (2011)
88. Javadifar A, "Foam cells as therapeutic targets in atherosclerosis with a focus on the regulatory roles of non-coding RNAs", Int J Mol Sci, 22, pp.2529~ (2021)
89. Wang N, "ABC transporters, cholesterol efflux, and implications for cardiovascular diseases", Adv Exp Med Biol, 1276, pp.67~83 (2020)
90. Tang CK, "Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages", Acta Pharmacol Sin, 25, pp.581~586 (2004)
91. Zhu X, "Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages", J Biol Chem, 283, pp.22930~22941 (2008)
92. Singaraja RR, "Efflux and atherosclerosis : the clinical and biochemical impact of variations in the ABCA1 gene", Arterioscler Thromb Vasc Biol, 23, pp.1322~1332 (2003)
93. Stamatikos A, "ABCA1 overexpression in endothelial cells in vitro enhances ApoAI-mediated cholesterol efflux and decreases inflammation", Hum Gene Ther, 30, pp.236~248 (2019)
94. Ma Z, "Liver X receptors and their agonists : targeting for cholesterol homeostasis and cardiovascular diseases", Curr Issues Mol Biol, 22, pp.41~64 (2017)
95. Zhao C, "Liver X receptor in cholesterol metabolism", J Endocrinol, 204, pp.233~240 (2010)
96. Murthy S, "LXR", RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells, 2002, pp.43, 1054~1064
97. Shin SK, "Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism", Mol Nutr Food Res, 55, pp.1829~1840 (2011)
98. Oppi S, "Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature", Eur Heart J, 41, pp.995~1005 (2020)
99. Han L, "PPARs : regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II : PPAR-β", δ and PPAR-γ, 2017, pp.13, 279~296
100. Chawla A, "A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis", Mol Cell, 7, pp.161~171 (2001)
101. Franceschelli S, "Hydroxytyrosol reduces foam cell formation and endothelial inflammation regulating the PPARγ", LXRα, Int J Mol Sci, pp.2023, 24[DOI]
102. Zhao GJ, "Antagonism of betulinic acid on LPS-mediated inhibition of ABCA1 and cholesterol efflux through inhibiting nuclear factor-kappaB signaling pathway and miR-33 expression", PLoS One, 8, pp.e74782~ (2013)
103. Yan S, "Anti-inflammatory effect of curcumin on the mouse model of myocardial infarction through regulating macrophage polarization", Mediators Inflamm, 2021, pp.9976912~ (2021)
104. Kunjathoor VV, "Scavenger receptors class A-I", II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages, 2002, pp.277, 49982~49988
105. Pirillo A, "LOX-1, OxLDL, and atherosclerosis", Mediators Inflamm, 2013, pp.152786~ (2013)
106. Sawamura T, "An endothelial receptor for oxidized low-density lipoprotein", Nature, 386, pp.73~77 (1997)
107. Hofnagel O, "Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells", Arterioscler Thromb Vasc Biol, 24, pp.1789~1795 (2004)
108. Mehta JL, "Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet", Circ Res, 100, pp.1634~1642 (2007)
109. Manning-Tobin JJ, "Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice", Arterioscler Thromb Vasc Biol, 29, pp.19~26 (2009)
110. Janabi M, "Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients", Arterioscler Thromb Vasc Biol, 20, pp.1953~1960 (2000)
111. Febbraio M, "Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice", J Clin Invest, 105, pp.1049~1056 (2000)
112. Li X, "Paeonol suppresses lipid accumulation in macrophages via upregulation of the ATP-binding cassette transporter A1 and downregulation of the cluster of differentiation 36", Int J Oncol, 46, pp.764~774 (2015)
113. Wang T, "Ganoderic acid A inhibits ox-LDL-induced THP-1-derived macrophage inflammation and lipid deposition via Notch1", PPARγ, Adv Clin Exp Med, pp.2021, 30[DOI]
114. Shen CY, "Bergaptol from blossoms of Citrus aurantium L. var. amara Engl inhibits LPS-induced inflammatory responses and ox-LDL-induced lipid deposition", Food Funct, 11, pp.4915~4926 (2020)

관련 논문AI추천